Daily Archives: 8 March 2025

Dual WEE1/YES1 Kinase Inhibitor MRANK-106 Secures FDA IND Clearance, Positioning MindRank in First-in-Class Oncology Pipeline

MindRank’s Second Clinical-stage PipelineAI-Powered Presicion Drug DesignHANGZHOU, China and LONDON, March 07, 2025 (GLOBE NEWSWIRE) — MindRank, a clinical stage artificial intelligence (AI)-empowered drug discovery company, announces today that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application for MRANK-106, a first-in-class, orally …

Read More »